These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15183152)

  • 1. Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells.
    Colombo M; Hamelin C; Kouassi E; Fournier M; Bernier J
    Clin Immunol; 2004 Jun; 111(3):311-22. PubMed ID: 15183152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation.
    Mukerjee N; McGinnis KM; Gnegy ME; Wang KK
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1192-9. PubMed ID: 11478781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. I. Suppression of T-cell activation.
    Shenker BJ; Rooney C; Vitale L; Shapiro IM
    Immunopharmacol Immunotoxicol; 1992; 14(3):539-53. PubMed ID: 1517533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AICAR suppresses IL-2 expression through inhibition of GSK-3 phosphorylation and NF-AT activation in Jurkat T cells.
    Jhun BS; Oh YT; Lee JY; Kong Y; Yoon KS; Kim SS; Baik HH; Ha J; Kang I
    Biochem Biophys Res Commun; 2005 Jul; 332(2):339-46. PubMed ID: 15910743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cells.
    Jhun BS; Lee JY; Oh YT; Lee JH; Choe W; Baik HH; Kim SS; Yoon KS; Ha J; Kang I
    Biochem Biophys Res Commun; 2006 Dec; 351(4):986-92. PubMed ID: 17097050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells.
    Jaalouk DE; Lejeune L; Couture C; Galipeau J
    Virol J; 2006 Nov; 3():97. PubMed ID: 17118192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
    Lin SJ; Cheng PJ; Hsiao SS
    Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulus dependence of the action of small-molecule inhibitors in the CD3/CD28 signalling network.
    Köhler K; Ganser A; André T; Roth G; Grosse-Hovest L; Jung G; Brock R
    ChemMedChem; 2008 Sep; 3(9):1404-11. PubMed ID: 18604819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.
    Evenou JP; Wagner J; Zenke G; Brinkmann V; Wagner K; Kovarik J; Welzenbach KA; Weitz-Schmidt G; Guntermann C; Towbin H; Cottens S; Kaminski S; Letschka T; Lutz-Nicoladoni C; Gruber T; Hermann-Kleiter N; Thuille N; Baier G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):792-801. PubMed ID: 19491325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH; Son CG; Jung U; Han SH
    Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues.
    Chae WJ; Lee HK; Han JH; Kim SW; Bothwell AL; Morio T; Lee SK
    Int Immunol; 2004 Sep; 16(9):1225-36. PubMed ID: 15302845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
    Wong VK; Zhou H; Cheung SS; Li T; Liu L
    J Cell Biochem; 2009 May; 107(2):303-15. PubMed ID: 19301261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro immune modulation by cadmium depends on the way of cell activation.
    Hemdan NY; Emmrich F; Sack U; Wichmann G; Lehmann J; Adham K; Lehmann I
    Toxicology; 2006 May; 222(1-2):37-45. PubMed ID: 16510232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells.
    Manicassamy S; Sadim M; Ye RD; Sun Z
    J Mol Biol; 2006 Jan; 355(3):347-59. PubMed ID: 16309697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.